Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of carboplatin, gemcitabine hydrochloride, and stereotactic body radiation therapy in gynecologic cancers has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Epithelial Cancer
• Ovarian Germ Cell Tumor
• Peritoneal Cancer
• Uterine Sarcoma
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Status: COMPLETED